SI2155788T1 - Bispecifični vezavni element specifičen za križane vrste - Google Patents

Bispecifični vezavni element specifičen za križane vrste

Info

Publication number
SI2155788T1
SI2155788T1 SI200830762T SI200830762T SI2155788T1 SI 2155788 T1 SI2155788 T1 SI 2155788T1 SI 200830762 T SI200830762 T SI 200830762T SI 200830762 T SI200830762 T SI 200830762T SI 2155788 T1 SI2155788 T1 SI 2155788T1
Authority
SI
Slovenia
Prior art keywords
species
cross
specific bispecific
bispecific binders
binders
Prior art date
Application number
SI200830762T
Other languages
English (en)
Slovenian (sl)
Inventor
Matthias Klinger
Tobias Raum
Doris Rau
Susanne Mangold
Roman Kischel
Ralf Lutterbuse
Patrick Hoffmann
Peter Kufer
Original Assignee
Amgen Res Munich Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Res Munich Gmbh filed Critical Amgen Res Munich Gmbh
Priority claimed from EP08735000A external-priority patent/EP2155788B1/en
Publication of SI2155788T1 publication Critical patent/SI2155788T1/sl

Links

SI200830762T 2007-04-03 2008-04-03 Bispecifični vezavni element specifičen za križane vrste SI2155788T1 (sl)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP07006988 2007-04-03
EP07006990 2007-04-03
US91366807P 2007-04-24 2007-04-24
EP07020646 2007-10-22
EP07020640 2007-10-22
EP07020641 2007-10-22
EP08004741 2008-03-13
EP08735000A EP2155788B1 (en) 2007-04-03 2008-04-03 Cross-species-specific bispecific binders
PCT/EP2008/002663 WO2008119566A2 (en) 2007-04-03 2008-04-03 Cross-species-specific bispecific binders

Publications (1)

Publication Number Publication Date
SI2155788T1 true SI2155788T1 (sl) 2012-11-30

Family

ID=42582614

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830762T SI2155788T1 (sl) 2007-04-03 2008-04-03 Bispecifični vezavni element specifičen za križane vrste

Country Status (8)

Country Link
JP (1) JP2010524435A (enExample)
DK (1) DK2155788T3 (enExample)
ES (1) ES2390243T3 (enExample)
NZ (1) NZ580746A (enExample)
PT (1) PT2155788E (enExample)
RS (1) RS52492B (enExample)
RU (1) RU2535992C2 (enExample)
SI (1) SI2155788T1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4059964A1 (en) * 2007-04-03 2022-09-21 Amgen Research (Munich) GmbH Cross-species-specific binding domain
HRP20120759T1 (hr) * 2007-04-03 2012-10-31 Amgen Research (Munich) Gmbh Bispecifična veziva specifična između vrsta
EP3974453A3 (en) * 2010-11-16 2022-08-03 Amgen Inc. Agents and methods for treating diseases that correlate with bcma expression
CN107903325B (zh) * 2011-05-16 2021-10-29 埃泰美德(香港)有限公司 多特异性fab融合蛋白及其使用方法
SI2714733T1 (sl) * 2011-05-21 2019-06-28 Macrogenics, Inc. CD3-vezavne molekule sposobne vezave na humani ali ne-humani CD3
HUE050156T2 (hu) 2013-12-17 2020-11-30 Genentech Inc Anti-CD3 antitestek és alkalmazási eljárások
JP6738285B2 (ja) * 2014-05-28 2020-08-12 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト ヒト及びカニクイザルｃｄ３イプシロンに結合する抗体
US10669337B2 (en) * 2014-07-25 2020-06-02 Cytomx Therapeutics, Inc. Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same
AR101400A1 (es) * 2014-07-31 2016-12-14 Amgen Res Munich Gmbh Constructo de anticuerpo de cadena individual biespecífico con distribución mejorada de tejido
JP2018520642A (ja) * 2015-05-01 2018-08-02 ジェネンテック， インコーポレイテッド マスク抗ｃｄ３抗体及びその使用方法
AU2017233121B2 (en) 2016-03-15 2023-12-21 Itabmed (Hk) Limited Multispecific Fab fusion proteins and use thereof
MX2019005438A (es) 2016-11-15 2019-08-16 Genentech Inc Dosificacion para tratamiento con anticuerpos bispecificos anti-cd20 / anti-cd3.
US10426424B2 (en) 2017-11-21 2019-10-01 General Electric Company System and method for generating and performing imaging protocol simulations
CR20200391A (es) 2018-02-08 2020-10-19 Genentech Inc Moléculas biespecíficas de unión al antígeno y métodos de uso
JP7548587B2 (ja) 2018-09-07 2024-09-10 アイタブメッド （エイチケイ） リミテッド 二重特異性抗原結合タンパク質及びその使用
US20230067182A1 (en) * 2019-11-29 2023-03-02 Boe Technology Group Co., Ltd. Data Processing Device and Method, and Computer Readable Storage Medium
US11845799B2 (en) 2019-12-13 2023-12-19 Genentech, Inc. Anti-Ly6G6D antibodies and methods of use
JP2022087602A (ja) * 2020-12-01 2022-06-13 株式会社バイオピーク 組換え大腸菌による有用タンパク質の生産性を向上するための培養方法
WO2022241235A1 (en) 2021-05-14 2022-11-17 Genentech, Inc. Methods for treatment of cd20-positive proliferative disorder with mosunetuzumab and polatuzumab vedotin
CN115932808B (zh) * 2022-11-04 2025-05-27 四川九洲电器集团有限责任公司 一种基于多特征融合的被动声纳智能探测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2179862C1 (ru) * 2000-12-26 2002-02-27 Общество с ограниченной ответственностью Научно-производственный центр "МедБиоСпектр" Лекарственное средство для предотвращения отторжения трансплантата, моноклональное антитело к cd3-антигену т-лимфоцитов человека, гибридома и способ лечения больных, имеющих реакцию острого отторжения трансплантата после пересадки почки
BRPI0410338A (pt) * 2003-05-31 2006-05-30 Micromet Ag composição farmacêutica compreendendo um constructo de anticorpo biespecìfico para epcam, processo para sua produção, uso de um constructo biespecìfico, kit contendo o mesmo e método para a prevenção, tratamento ou alìvio de uma doença tumoral
US7235641B2 (en) * 2003-12-22 2007-06-26 Micromet Ag Bispecific antibodies
AU2005250499B2 (en) * 2004-06-03 2011-12-08 Novimmune S.A. Anti-CD3 antibodies and methods of use thereof
EP1933868A2 (en) * 2005-09-12 2008-06-25 NovImmune SA Anti-cd3 antibody formulations
EP1940881B1 (en) * 2005-10-11 2016-11-30 Amgen Research (Munich) GmbH Compositions comprising cross-species-specific antibodies and uses thereof

Also Published As

Publication number Publication date
RS52492B (sr) 2013-02-28
JP2010524435A (ja) 2010-07-22
RU2009136913A (ru) 2011-06-20
RU2535992C2 (ru) 2014-12-20
DK2155788T3 (da) 2012-10-08
NZ580746A (en) 2012-05-25
ES2390243T3 (es) 2012-11-07
PT2155788E (pt) 2012-09-25

Similar Documents

Publication Publication Date Title
IL201338A0 (en) Cross - species - specific bispecific binders
SI2155788T1 (sl) Bispecifični vezavni element specifičen za križane vrste
GB2496951C (en) Binders
IL234081B (en) Antibody binds cd3–epsilon in different species
DK200800103A (en) Integreret føringskant for vindturbineblad
IL202616A0 (en) Substituted imidazoheterocycles
ZA201001683B (en) Substituted piperidino-dihydrothienopyrimidines
IL201340A (en) Antidote 3dc - epsilon in various species
GB0724258D0 (en) Novel combinations
GB0701574D0 (en) Wave-dissipating block
GB0704817D0 (en) Railbond
GB0704569D0 (en) Pentalenes
GB0807972D0 (en) Area-partitioning
IL200965A0 (en) Substituted tetrahydropyrroloquinolines
GB0700595D0 (en) Holecutter
GB0712532D0 (en) Binders
GB0812743D0 (en) Binders
GB0721236D0 (en) File clipz
GB0724281D0 (en) Combinations
GB0725328D0 (en) Data-handleing means
GB0603219D0 (en) Binders
GB0724415D0 (en) CV-kinisis II
ZA201000435B (en) Substituted imidazoheterocycles
HU0700147V0 (en) Block
GB0711472D0 (en) Block